HPV Testing to Be More Widely Available Throughout China

Free HPV testing will be given to underprivileged women in China, especially in less populated and remote regions.

Qiagen (Hilden, Germany) is expanding access to Human papillomavirus (HPV) screening in China through a comarketing agreement with KingMed Diagnostics (Guangzhou, China), China’s largest independent laboratory network.

The "gold standard" in testing for high-risk types of HPV, the primary cause of cervical cancer, is Qiagen's digene HPV Test

KingMed Diagnostics will function as a centralized lab, allowing smaller hospitals and those in less-populated areas to offer the digene HPV Test and send samples to KingMed Diagnostics for processing and analysis.

The agreement is a landmark for Qiagen’s molecular diagnostics franchise in China and its focus on driving growth in emerging markets. More...